This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Celldex Therapeutics Inc
CLDX : NASDAQ : Health Care
$12.37 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,905,600
10/01/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CLDX CELLDEX THERAPEUTICS INC 14.16 1265.96 n/m 2.61 -71.87
ACOR ACORDA THERAPEUTICS INC 35.54 1483.62 77.26 355.16 11.74
DYAX DYAX CORP 10.37 1412.45 n/m 64.25 22.36
CLVS CLOVIS ONCOLOGY INC 40.02 1359.24 n/m 13.63 n/a
PTCT PTC THERAPEUTICS INC 44.47 1337.21 n/m 31.59 360.95
CBPO CHINA BIOLOGIC PRODUCTS INC 53.89 1319.28 23.13 212.09 8.91
INSY INSYS THERAPEUTICS INC 36.20 1249.26 24.41 166.74 319.04
KERX KERYX BIOPHARMACEUTICALS INC 13.15 1207.43 n/m 10.00 42.85
HALO HALOZYME THERAPEUTICS INC 9.63 1206.70 n/m 58.86 10.20
PDLI PDL BIOPHARMA INC 7.51 1206.39 4.39 439.12 7.96
PTLA PORTOLA PHARMACEUTICALS INC 26.38 1092.05 n/m 9.61 269.39
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CLDX Ind Avg S&P 500
n/m 81.36 19.49
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs